LIBERIA
In Liberia, malaria is the leading cause of attendance in outpatient departments and the number one cause of inpatient deaths. Recent household surveys show artemisinin combination therapy coverage in children under five years of age at 81 percent; intermittent preventive treatment for pregnant women uptake at 55 percent; and households with at least one ITN at 62 percent. PMI and other partners are providing technical and financial support to reduce malaria burden in Liberia. The Liberian Ministry of Health’s Joint Annual Health Sector Review Report of 2016 indicated that malaria services were mostly available and provided by 97 percent of the health facilities across the country.
Country Fact Sheet
LIBERIA MALARIA OPERATIONAL PLANS (MOPs)
The Malaria Operational Plans below are detailed 1-year implementation plans for PMI partner countries. Each plan reviews the current status of malaria control and prevention policies and interventions, identifies challenges and unmet needs to achieve PMI goals, and provides a description of planned PMI-funded activities. Each Malaria Operational Plan has been endorsed by the U.S. Global Malaria Coordinator and reflects collaborative discussions with the national malaria control programs and partners in country. Changes to these plans are reflected in revised postings.
Page 1 of 1
Page 1 of 1
STORIES
Partnering with Facebook to promote prompt care-seeking for fever during COVID-19
While scrolling through their newsfeeds in August, nearly 28,500 Facebook [...]
PMI and USAID Improve Commodity Warehousing in Liberia
Section of the Freeport Warehouse, Monrovia, Liberia Photo credit: [...]
Fighting Substandard and Falsified Medicines in Liberia
USP/PQM training Liberia laboratory staff on quality control of [...]
